Michael Møller

Research interests

Publications

• Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

  Cancer Immunology Research · 2019 · https://doi.org/10.1158/2326-6066.cir-18-0439

• Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

  Blood · 2018 · https://doi.org/10.1182/blood-2018-03-838524

• DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study

  Blood · 2017 · https://doi.org/10.1182/blood-2016-12-755496

• Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations

  Allergy · 2017 · https://doi.org/10.1111/all.13237

• Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

  Oncotarget · 2015 · https://doi.org/10.18632/oncotarget.6262

• Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis

  Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.57.7080

• Epidemiology of systemic mastocytosis in Denmark

  British Journal of Haematology · 2014 · 10.1111/bjh.12916

• Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis

  American Journal of Hematology · 2014 · https://doi.org/10.1002/ajh.23672

• Prevalence and Clinical Implications of Epstein–Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries

  Clinical Cancer Research · 2014 · https://doi.org/10.1158/1078-0432.ccr-13-3157

• MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

  Blood · 2013 · https://doi.org/10.1182/blood-2012-10-460063

• CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

  Blood · 2013 · 10.1182/blood-2012-10-461848

• Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

  Modern Pathology · 2013 · https://doi.org/10.1038/modpathol.2013.214

• Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.41.4342

• Pneumothorax in cardiac pacing: a population-based cohort study of 28 860 Danish patients

  EP Europace · 2012 · https://doi.org/10.1093/europace/eus054

• Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

  Leukemia · 2012 · https://doi.org/10.1038/leu.2012.83

• High Levels of Nuclear MYC Protein Predict the Presence of MYC Rearrangement in Diffuse Large B-cell Lymphoma

  The American Journal of Surgical Pathology · 2012 · https://doi.org/10.1097/pas.0b013e318244e2ba

• Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

  Haematologica · 2012 · https://doi.org/10.3324/haematol.2012.066209

• Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

  Blood · 2012 · https://doi.org/10.1182/blood-2012-05-433334

• Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay

  Journal of Molecular Diagnostics · 2011 · https://doi.org/10.1016/j.jmoldx.2010.10.004

• Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients

  European Heart Journal · 2011 · https://doi.org/10.1093/eurheartj/ehq497

• Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study

  Blood · 2008 · https://doi.org/10.1182/blood-2008-01-129783

• The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis – impact on disease phenotype

  European Journal Of Haematology · 2007 · https://doi.org/10.1111/j.1600-0609.2007.00960.x

• Diffuse large B‐cell lymphoma: clinical implications of extranodal versus nodal presentation – a population‐based study of 1575 cases

  British Journal of Haematology · 2003 · 10.1046/j.1365-2141.2003.04749.x

• Malignant Transformation of Neurofibromas in Neurofibromatosis 1 Is Associated with CDKN2A/p16 Inactivation

  American Journal Of Pathology · 1999 · 10.1016/s0002-9440(10)65507-1

• Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis

  European Journal of Cancer · 1994 · https://doi.org/10.1016/0959-8049(94)00311-r

Current projects

No projects listed.